Literature DB >> 9580528

Rupture of mitral chorda tendinea following blunt chest trauma.

A R Grinberg1, J D Finkielman, D Piñeiro, H Festa, C Cazenave.   

Abstract

Acute mitral insufficiency, originated from rupture of mitral chordae tendineae secondary to nonpenetrating thoracic trauma, is an unusual condition. This diagnosis is difficult to establish because physical examination, electrocardiogram, and cardiac enzymes are neither sensitive nor specific. The diagnosis of rupture must be quickly established because this disorder may be fatal. This paper reports the case of a patient with acute mitral insufficiency secondary to a mitral valve chord rupture a week after a nonpenetrating thoracic trauma.

Entities:  

Mesh:

Year:  1998        PMID: 9580528      PMCID: PMC6655305          DOI: 10.1002/clc.4960210415

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  Clinical characteristics of acute mitral regurgitation due to ruptured chordae tendineae in infancy-experience at a single institution.

Authors:  Tsukasa Torigoe; Heima Sakaguchi; Masataka Kitano; Ken-Ichi Kurosaki; Isao Shiraishi; Kouji Kagizaki; Hajime Ichikawa; Toshikatsu Yagihara
Journal:  Eur J Pediatr       Date:  2011-07-08       Impact factor: 3.183

2.  Acute progressive mitral regurgitation resulting from chordal rupture in infants.

Authors:  Hiroko Asakai; Yukihiro Kaneko; Masahide Kaneko; Yasushi Misaki; Ikuya Achiwa; Yasutaka Hirata; Hitoshi Kato
Journal:  Pediatr Cardiol       Date:  2011-03-02       Impact factor: 1.655

3.  Fluid-Structure Interaction Analysis of Ruptured Mitral Chordae Tendineae.

Authors:  Milan Toma; Charles H Bloodworth; Eric L Pierce; Daniel R Einstein; Richard P Cochran; Ajit P Yoganathan; Karyn S Kunzelman
Journal:  Ann Biomed Eng       Date:  2016-09-13       Impact factor: 3.934

4.  A neonate with the rupture of mitral chordae tendinae associated with maternal-derived anti-SSA antibody.

Authors:  Akiko Hamaoka; Isao Shiraishi; Masaaki Yamagishi; Kenji Hamaoka
Journal:  Eur J Pediatr       Date:  2008-08-29       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.